Literature DB >> 7563170

Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia.

A J Guidi1, G Abu-Jawdeh, B Berse, R W Jackman, K Tognazzi, H F Dvorak, L F Brown.   

Abstract

BACKGROUND: Angiogenesis is a critical factor in the progression of solid tumors, including cervical cancers. The mechanisms responsible for angiogenesis in cervical neoplasia, however, are not well defined.
PURPOSE: Our goal was to determine the relationship between angiogenesis and the expression of the angiogenic cytokine vascular permeability factor (VPF), also known as vascular endothelial growth factor, and its receptors in cervical neoplasia.
METHODS: Sixty-six cervical biopsy specimens were evaluated; among these, 16 samples were designated as benign, 17 as low-grade squamous intraepithelial lesions, 18 as high-grade squamous intraepithelial lesions, and 15 as invasive squamous cell carcinomas. Histologic sections immunostained for factor VIII-related antigen were evaluated quantitatively for microvessel density and for the presence of epithelial-stromal vascular cuffing. Sections were also evaluated for VPF messenger RNA (mRNA) expression by in situ hybridization.
RESULTS: VPF mRNA expression, epithelial-stromal vascular cuffing, and microvessel density counts were significantly increased in invasive carcinoma and in high-grade intraepithelial lesions as compared with low-grade intraepithelial lesions and benign squamous epithelium. Vascular cuffing and increased microvessel density counts were also significantly associated with increased VPF mRNA expression.
CONCLUSIONS: These observations suggest that VPF is an important angiogenic factor in cervical neoplasia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7563170     DOI: 10.1093/jnci/87.16.1237

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  52 in total

Review 1.  Angiogenesis and melanoma.

Authors:  J P Dutcher
Journal:  Curr Oncol Rep       Date:  2001-07       Impact factor: 5.075

Review 2.  Targeting angiogenesis in advanced cervical cancer.

Authors:  Ramez N Eskander; Krishnansu S Tewari
Journal:  Ther Adv Med Oncol       Date:  2014-11       Impact factor: 8.168

Review 3.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

Review 4.  Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast.

Authors:  A Rice; C M Quinn
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

5.  Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer.

Authors:  M Branca; C Giorgi; D Santini; L Di Bonito; M Ciotti; A Benedetto; P Paba; S Costa; D Bonifacio; P Di Bonito; L Accardi; C Favalli; K Syrjänen
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

6.  Three-dimensional endothelial-tumor epithelial cell interactions in human cervical cancers.

Authors:  V Chopra; T V Dinh; E V Hannigan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-06       Impact factor: 2.416

Review 7.  Development of bevacizumab in advanced cervical cancer: pharmacodynamic modeling, survival impact and toxicology.

Authors:  Ramez N Eskander; Krishnansu S Tewari
Journal:  Future Oncol       Date:  2015       Impact factor: 3.404

8.  Distinct role of PLCbeta3 in VEGF-mediated directional migration and vascular sprouting.

Authors:  Resham Bhattacharya; Junhye Kwon; Xiujuan Li; Enfeng Wang; Sujata Patra; John Paul Bida; Zeljko Bajzer; Lena Claesson-Welsh; Debabrata Mukhopadhyay
Journal:  J Cell Sci       Date:  2009-04-01       Impact factor: 5.285

Review 9.  Optical imaging for cervical cancer detection: solutions for a continuing global problem.

Authors:  Nadhi Thekkek; Rebecca Richards-Kortum
Journal:  Nat Rev Cancer       Date:  2008-09       Impact factor: 60.716

Review 10.  Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants.

Authors:  G Neufeld; T Cohen; H Gitay-Goren; Z Poltorak; S Tessler; R Sharon; S Gengrinovitch; B Z Levi
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.